New Lung Research May Improve Detection, Monitor of Diseases
An international team of scientists found that immune cells called monocytes could be used to predict lung abnormalities and their progression.
Read MorePosted by Andy Lundin | Feb 2, 2022 | Disease States |
An international team of scientists found that immune cells called monocytes could be used to predict lung abnormalities and their progression.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Lung Cancer |
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read MorePosted by Andy Lundin | Dec 15, 2021 | Clinical Chemistry, Lung Cancer |
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 10, 2021 | Lung Cancer |
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read More